Efficacy of DAA-based Antiviral Therapies for HCV Patients with Chronic Kidney Disease: A Meta-analysis
Peyman Sanjari Pirayvatlou, Seyyed Moayed Alavian, Sasan Sanjari Pirayvatlou, Pouyan Sanjari Pirayvatlou, Mina Mahboodi & Madjad Einollahi · Journal of Pharmaceutical Research International · 2019
Context: HCV infection in patients with chronic kidney disease (CKD) is important to be treated because it's associated with increased healthcare costs, utilization and is pertained with decrease in survival rate of HCV-infected patients who also have chronic kidney disease. Dire...
Open access
Research Article
10.9734/jpri/2019/v31i630328